Replies to post #226553 on Biotech Values

[DewDiligence]

MRK CEO on JPM webcast: Keytruda and Gardasil will continue strong growth in China even without inclusion in the NDRL (government reimbursement) list. Gardasil sales (worldwide) are constrained by production capacity, not demand.

[DewDiligence]

MRK 4Q19 results/2020 guidance…

PR:
https://finance.yahoo.com/news/merck-announces-fourth-quarter-full-114700713.html

CC slides (including spinoff info):
https://s21.q4cdn.com/488056881/files/doc_financials/2019/q4/4Q19-Earnings-Deck_MRK.pdf

--
2020 non-GAAP EPS guidance is $5.62-5.77, +8% to +11% YoY.